Co-expression of Matrix Metalloproteinase 9 (MMP9) and Motility-related Protein-1 (MRP-1/CD9) in Human Breast Cancer
International Journal of Cancer Management · 2022
DOI: 10.5812/ijcm-105009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer Management, 2022. Verfasst von Shabnam Khalilnezhad und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Controversial evidence exists regarding the metastasis-suppressor or promoting activity of motility-related protein-1 (MRP-1/CD9) in breast cancer (BC). Objectives: we aimed at investigating the possible correlation of CD9 with a metastasis marker matrix metalloproteinase 9 (MMP9) in human BC tissues.
Methods
A total of 19 BC and 5 normal breast tissues were analyzed. The mRNA expression of CD9 and MMP9 was measured by quantitative PCR. The correlation of genes’ expression with each other and clinicopathological features (i. e. tumor pathology, grade, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2), P53, and KI67) was tested by relevant statistical analysis methods.
Results
There was no significant difference between patients with BC and the control group regarding the expression of MMP9 (P = 0.394) and CD9 (P = 0.887). A significant strong positive correlation was observed between CD9 and MMP-9 expressions (r = 0.761 and P = 0.0002). The MMP9 expression was significantly higher in ER or PR positive compared to ER or PR negative tumors (P = 0.046).
Conclusions
Given the strong correlation with MMP9, it seems that CD9 might have a role in metastasis in human BC. However, much more studies are required to further support this hypothesis.
Zitieren
APA
Khalilnezhad, S., Safaralizadeh, R., Feizi, M. A. H., Khalilnezhad, A., & Amani, D. (2022). Co-expression of Matrix Metalloproteinase 9 (MMP9) and Motility-related Protein-1 (MRP-1/CD9) in Human Breast Cancer. International Journal of Cancer Management. https://doi.org/10.5812/ijcm-105009
Vancouver
Khalilnezhad S, Safaralizadeh R, Feizi MAH, Khalilnezhad A, Amani D. Co-expression of Matrix Metalloproteinase 9 (MMP9) and Motility-related Protein-1 (MRP-1/CD9) in Human Breast Cancer. International Journal of Cancer Management. 2022. doi:10.5812/ijcm-105009
BibTeX
@article{Khalilnezhad2022,
author = {Khalilnezhad, Shabnam and Safaralizadeh, Reza and Feizi, Mohammad Ali Hosseinpour and Khalilnezhad, Ahad and Amani, Davar},
title = {Co-expression of Matrix Metalloproteinase 9 (MMP9) and Motility-related Protein-1 (MRP-1/CD9) in Human Breast Cancer},
journal = {International Journal of Cancer Management},
year = {2022},
doi = {10.5812/ijcm-105009}
}
EUVIMED